We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LSEG:LSELondon Stock Exchange Group plc Analysis

Data as of 2026-03-10 - not real-time

£8,662.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

LSEG is currently trading below its short‑term moving averages, with the 20‑day SMA sitting beneath the 50‑day SMA and the price also under the 200‑day SMA, signalling a bearish technical backdrop. The RSI hovers in the upper‑mid range, suggesting limited upside momentum, while the MACD histogram remains positive, hinting at a potential near‑term reversal but not enough to offset the prevailing downtrend. Valuation metrics reinforce a cautionary stance: the price‑to‑earnings multiple is well above the sector average and the discounted cash‑flow estimate lies substantially lower than the market price, indicating the stock may be overvalued at present.
Fundamentally, the company posts solid revenue growth, strong gross margins and a healthy dividend yield that appears sustainable given its cash flow generation. Recent strategic news – notably the partnership with ASX to upgrade its trading platform and growing investor confidence in AI‑driven data services – supports a medium‑term upside narrative, while activist interest underscores confidence in the firm’s long‑term strategic direction despite short‑term pricing pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish momentum
  • High valuation relative to peers
  • Recent sharp price decline increasing short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic partnership with ASX expanding market footprint
  • Growing demand for AI‑enhanced financial data
  • Sustainable dividend and strong cash flow generation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term tailwinds in data and analytics services
  • Regulatory environment relatively stable for exchange operators
  • Valuation remains premium, tempering upside expectations

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin13.36%
P/E Ratio37.0
ROE6.37%
ROA0.19%
Debt/Equity52.97
P/B Ratio222.9
Op. Cash Flow£3.6B
Free Cash Flow£2.1B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI59.8
Support£7,012.00
Resistance£8,990.00
MA 20£8,061.00
MA 50£8,357.64
MA 200£9,239.92
MACDBullish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair Value£5,354.69
Target Price£12,231.77
Upside/Downside41.21%
GradeOvervalued
TypeGrowth
Dividend Yield1.71%

Risk Assessment

Beta0.23
Volatility57.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.